IVT-Shigella

N/A

Report date: 2025/12/26 09:51:48

Base Information

Drug NameIVT-Shigella

Drug Alias NameShigella sonnei/flexneri 3a/boydii 6 vaccine (Inventprise)quadrivalent polysaccharide conjugated vaccine (Inventprise)Shigella sonnei/flexneri 3a/boydii 6 antigen vaccine (Inventprise)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsDiarrheaDysentery, Bacillary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesInventprise LLC

China Registration ClassN/A

Develop Information

Active CompaniesInventprise LLC

Inactive CompaniesN/A

Active IndicationsDiarrheaDysentery, Bacillary

Inactive IndicationsN/A

Other Information

ATC CodeN/A